Posted 05 February, 2024

Alto Neuroscience, Inc. IPO completed

IPO completed detected for ticker NYSE:ANRO in a 424B4 filed on 05 February, 2024.

  This is our initial public offering, and prior to this offering there has been no public market for our common stock.  

Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of Alto Neuroscience, Inc.
Health Care/Life Sciences • Biotechnology
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of psychiatric drugs. Its pipeline is composed of five clinical-stage assets which initially target depressive disorder and schizophrenia population. The company was founded by Amit Etkin, Dan Segal, and Wei Wu on March 25, 2019 and is headquartered in Los Altos, CA.
Market Cap
View Company Details